{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T09:08:17Z","timestamp":1793178497621,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Endocrine society of India"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00198-024-07328-6","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T21:43:30Z","timestamp":1735335810000},"page":"311-322","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cost-effectiveness of FRAX\u00ae-based intervention thresholds for management of osteoporosis in Indian women: a Markov microsimulation model analysis"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6865-5554","authenticated-orcid":false,"given":"Lakshmi","family":"Nagendra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Reginster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay Kumar","family":"Bhadada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saptarshi","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deep","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mickael","family":"Hiligsmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"key":"7328_CR1","unstructured":"Nations U. United Nations. United Nations (2024) Population. Available from: https:\/\/www.un.org\/en\/global-issues\/population. Accessed 15 Jun 2024"},{"key":"7328_CR2","unstructured":"Home | Government of India [Internet] (2024). Available from: https:\/\/censusindia.gov.in\/census.website\/. Accessed 16 Jun 2024"},{"key":"7328_CR3","unstructured":"UNFPA India [Internet] (2024) India ageing, elderly to make up 20% of population by 2050: UNFPA report. Available from: https:\/\/india.unfpa.org\/en\/news\/india-ageing-elderly-make-20-population-2050-unfpa-report. Accessed 16 Jun 2024"},{"issue":"4","key":"7328_CR4","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4103\/2230-8210.137485","volume":"18","author":"A Mithal","year":"2014","unstructured":"Mithal A, Bansal B, Kyer CS, Ebeling P (2014) The asia-pacific regional audit-epidemiology, costs, and burden of osteoporosis in India 2013: a report of International osteoporosis foundation. Indian J Endocrinol Metab 18(4):449\u2013454","journal-title":"Indian J Endocrinol Metab"},{"issue":"7","key":"7328_CR5","doi-asserted-by":"publisher","first-page":"841","DOI":"10.2147\/IJWH.S54623","volume":"19","author":"AV Khadilkar","year":"2015","unstructured":"Khadilkar AV, Mandlik RM (2015) Epidemiology and treatment of osteoporosis in women: an Indian perspective. Int J Womens Health 19(7):841\u2013850","journal-title":"Int J Womens Health"},{"issue":"3","key":"7328_CR6","first-page":"245","volume":"27","author":"D Barik","year":"2015","unstructured":"Barik D, Thorat A (2015) Issues of unequal access to public health in India. Front Public Health 27(3):245","journal-title":"Front Public Health"},{"issue":"1","key":"7328_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s11657-021-00954-1","volume":"16","author":"SK Bhadada","year":"2021","unstructured":"Bhadada SK, Chadha M, Sriram U, Pal R, Paul TV, Khadgawat R et al (2021) The Indian society for bone and mineral research (ISBMR) position statement for the diagnosis and treatment of osteoporosis in adults. Arch Osteoporos 16(1):102","journal-title":"Arch Osteoporos"},{"issue":"1","key":"7328_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11657-021-00931-8","volume":"16","author":"L Nagendra","year":"2021","unstructured":"Nagendra L, Bhavani N, Menon VU, Pavithran PV, Menon AS, Abraham N et al (2021Apr 14) FRAX-based osteoporosis treatment guidelines for resource-poor settings in India. Arch Osteoporos 16(1):69","journal-title":"Arch Osteoporos"},{"issue":"4","key":"7328_CR9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00198-007-0550-6","volume":"19","author":"ANA Tosteson","year":"2008","unstructured":"Tosteson ANA, Melton LJ, Dawson-Hughes B, Baim S, Favus MJ, Khosla S et al (2008) Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 19(4):437\u2013447","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"7328_CR10","unstructured":"Pharmaceuticals & Medical Devices Bureau of India [Internet] (2024) Available from: https:\/\/janaushadhi.gov.in\/ProductList.aspx. Accessed 16 Jun 2024"},{"issue":"5","key":"7328_CR11","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1524-4733.2008.00497.x","volume":"12","author":"M Hiligsmann","year":"2009","unstructured":"Hiligsmann M, Ethgen O, Bruy\u00e8re O, Richy F, Gathon HJ, Reginster JY (2009) Development and validation of a Markov microsimulation model for the economic evaluation of treatments in osteoporosis. Value Health J Int Soc Pharmacoeconomics Outcomes Res 12(5):687\u2013696","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"key":"7328_CR12","doi-asserted-by":"publisher","first-page":"100241","DOI":"10.1016\/j.lansea.2023.100241","volume":"16","author":"D Sharma","year":"2023","unstructured":"Sharma D, Prinja S, Aggarwal AK, Rajsekar K, Bahuguna P (2023) Development of the Indian Reference Case for undertaking economic evaluation for health technology assessment. Lancet Reg Health Southeast Asia 16:100241","journal-title":"Lancet Reg Health Southeast Asia"},{"issue":"1","key":"7328_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00198-018-4744-x","volume":"30","author":"M Hiligsmann","year":"2019","unstructured":"Hiligsmann M, Reginster JY, Tosteson ANA, Bukata SV, Saag KG, Gold DT et al (2019) Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts\u2019 consensus meeting organized by the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO) and the US branch of the international osteoporosis foundation. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 30(1):45\u201357","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"4","key":"7328_CR14","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00198-019-04839-5","volume":"30","author":"EL Yong","year":"2019","unstructured":"Yong EL, Ganesan G, Kramer MS, Logan S, Lau TC, Cauley JA et al (2019) Hip fractures in Singapore: ethnic differences and temporal trends in the new millennium. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 30(4):879\u2013886","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"1","key":"7328_CR15","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s11657-019-0664-4","volume":"14","author":"M Chandran","year":"2019","unstructured":"Chandran M, Lau TC, Gagnon-Arpin I, Dobrescu A, Li W, Leung MYM et al (2019) The health and economic burden of osteoporotic fractures in Singapore and the potential impact of increasing treatment rates through more pharmacological options. Arch Osteoporos 14(1):114","journal-title":"Arch Osteoporos"},{"issue":"4","key":"7328_CR16","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","volume":"15","author":"CM Klotzbuecher","year":"2000","unstructured":"Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res Off J Am Soc Bone Miner Res 15(4):721\u2013739","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"3","key":"7328_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00198-003-1514-0","volume":"15","author":"O Johnell","year":"2004","unstructured":"Johnell O, Kanis JA, Od\u00e9n A, Sernbo I, Redlund-Johnell I, Petterson C et al (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 15(3):175\u2013179","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"2","key":"7328_CR18","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.bone.2004.03.024","volume":"35","author":"JA Kanis","year":"2004","unstructured":"Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35(2):375\u2013382","journal-title":"Bone"},{"key":"7328_CR19","unstructured":"India - Sample Registration System (SRS)-Statistical Report 2018 [Internet] (2024) Available from: https:\/\/censusindia.gov.in\/nada\/index.php\/catalog\/44374. Accessed 12 Jun 2024"},{"issue":"2","key":"7328_CR20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.semarthrit.2019.01.006","volume":"49","author":"M Hiligsmann","year":"2019","unstructured":"Hiligsmann M, Williams SA, Fitzpatrick LA, Silverman SS, Weiss R, Reginster JY (2019) Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for United States women at increased risk of fracture. Semin Arthritis Rheum 49(2):184\u201396","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"7328_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0033-3506(05)80614-6","volume":"105","author":"MJ Parker","year":"1991","unstructured":"Parker MJ, Anand JK (1991) What is the true mortality of hip fractures? Public Health 105(6):443\u2013446","journal-title":"Public Health"},{"key":"7328_CR22","unstructured":"Department of Community Medicine & School of Public Health PGIMER Chandigarh [Internet] (2024) Available from: https:\/\/www.healtheconomics.pgisph.in\/costing_web\/. Accessed 12 Jun 2024"},{"key":"7328_CR23","unstructured":"Reserve Bank of India - Reference Rate Archive [Internet] (2024) Available from: https:\/\/www.rbi.org.in\/scripts\/ReferenceRateArchive.aspx. Accessed 11 Sept 2024"},{"issue":"13","key":"7328_CR24","doi-asserted-by":"publisher","first-page":"04018","DOI":"10.7189\/jogh.13.04018","volume":"17","author":"G Jyani","year":"2023","unstructured":"Jyani G, Prinja S, Garg B, Kaur M, Grover S, Sharma A et al (2023) Health-related quality of life among Indian population: the EQ-5D population norms for India. J Glob Health 17(13):04018","journal-title":"J Glob Health"},{"issue":"3","key":"7328_CR25","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00198-012-2240-2","volume":"24","author":"F Borgstr\u00f6m","year":"2013","unstructured":"Borgstr\u00f6m F, Lekander I, Iverg\u00e5rd M, Str\u00f6m O, Svedbom A, Alekna V et al (2013) The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)\u2013quality of life during the first 4 months after fracture. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 24(3):811\u2013823","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"4","key":"7328_CR26","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s00223-008-9117-6","volume":"82","author":"M Hiligsmann","year":"2008","unstructured":"Hiligsmann M, Ethgen O, Richy F, Reginster JY (2008) Utility values associated with osteoporotic fracture: a systematic review of the literature. Calcif Tissue Int 82(4):288\u2013292","journal-title":"Calcif Tissue Int"},{"key":"7328_CR27","unstructured":"Overview | Bisphosphonates for treating osteoporosis | Guidance | NICE [Internet]. NICE (2017) Available from: https:\/\/www.nice.org.uk\/guidance\/ta464. Accessed 12 Jun 2024"},{"issue":"3","key":"7328_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s40273-014-0231-1","volume":"33","author":"M Hiligsmann","year":"2015","unstructured":"Hiligsmann M, Evers SM, Ben Sedrine W, Kanis JA, Ramaekers B, Reginster JY et al (2015) A systematic review of cost-effectiveness analyses of drugs for postmenopausal osteoporosis. Pharmacoeconomics 33(3):205\u2013224","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"7328_CR29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00198-014-2900-5","volume":"26","author":"O Str\u00f6m","year":"2015","unstructured":"Str\u00f6m O, Landfeldt E, Garellick G (2015) Residual effect after oral bisphosphonate treatment and healthy adherer effects\u2013the Swedish Adherence Register Analysis (SARA). Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 26(1):315\u2013325","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"7","key":"7328_CR30","first-page":"35","volume":"20","author":"AO Iuga","year":"2014","unstructured":"Iuga AO, McGuire MJ (2014) Adherence and health care costs. Risk Manag Healthc Policy 20(7):35\u201344","journal-title":"Risk Manag Healthc Policy"},{"issue":"5","key":"7328_CR31","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jval.2012.02.001","volume":"15","author":"M Hiligsmann","year":"2012","unstructured":"Hiligsmann M, McGowan B, Bennett K, Barry M, Reginster JY (2012) The clinical and economic burden of poor adherence and persistence with osteoporosis medications in Ireland. Value Health J Int Soc Pharmacoeconomics Outcomes Res 15(5):604\u2013612","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"issue":"4","key":"7328_CR32","doi-asserted-by":"publisher","first-page":"e027049","DOI":"10.1136\/bmjopen-2018-027049","volume":"9","author":"F Fatoye","year":"2019","unstructured":"Fatoye F, Smith P, Gebrye T, Yeowell G (2019) Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review. BMJ Open 9(4):e027049","journal-title":"BMJ Open"},{"issue":"10","key":"7328_CR33","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1359\/jbmr.080510","volume":"23","author":"AM Gallagher","year":"2008","unstructured":"Gallagher AM, Rietbrock S, Olson M, van Staa TP (2008) Fracture outcomes related to persistence and compliance with oral bisphosphonates. J Bone Miner Res Off J Am Soc Bone Miner Res 23(10):1569\u20131575","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"7328_CR34","doi-asserted-by":"publisher","first-page":"115682","DOI":"10.1016\/j.bone.2020.115682","volume":"142","author":"D Liew","year":"2021","unstructured":"Liew D, Chapurlat RD, Sornay-Rendu E, Lespessailles E, Peng Y, Seeman E (2021) Cost-effectiveness of treatment of women aged 70 years and older with both osteopenia and microstructural deterioration. Bone 142:115682","journal-title":"Bone"},{"issue":"1","key":"7328_CR35","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11657-020-00756-x","volume":"15","author":"R Rajan","year":"2020","unstructured":"Rajan R, Paul J, Cherian KE, Asha HS, Kapoor N, Paul TV (2020) FRAX\u00ae with or without BMD and TBS predicts fragility fractures in community-dwelling rural southern Indian postmenopausal women. Arch Osteoporos 15(1):82","journal-title":"Arch Osteoporos"},{"issue":"1","key":"7328_CR36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11657-018-0536-3","volume":"13","author":"B Bansal","year":"2018","unstructured":"Bansal B, Mithal A, Chopra SR, Bhanot S, Kuchay MS, Farooqui KJ (2018) Judicious use of DXA-BMD in assessing fracture risk by using clinical risk factors in the Indian population. Arch Osteoporos 13(1):115","journal-title":"Arch Osteoporos"},{"issue":"1","key":"7328_CR37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00198-020-05536-4","volume":"32","author":"M Chandran","year":"2021","unstructured":"Chandran M, Ganesan G, Tan KB, Reginster JY, Hiligsmann M (2021) Cost-effectiveness of FRAX\u00ae-based intervention thresholds for management of osteoporosis in Singaporean women. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 32(1):133\u2013144","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"4","key":"7328_CR38","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00198-021-05876-9","volume":"32","author":"M Chandran","year":"2021","unstructured":"Chandran M, Ganesan G, Tan KB, Reginster JY, Hiligsmann M (2021) Using health-economic evidence to support policy-level decision-making in Singapore-sensitivity analysis that provides further confidence in fracture probability-based cost-effective intervention thresholds. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 32(4):787\u2013789","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"11","key":"7328_CR39","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1007\/s00198-011-1869-6","volume":"23","author":"K Lippuner","year":"2012","unstructured":"Lippuner K, Johansson H, Borgstr\u00f6m F, Kanis JA, Rizzoli R (2012) Cost-effective intervention thresholds against osteoporotic fractures based on FRAX\u00ae in Switzerland. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 23(11):2579\u20132589","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"1","key":"7328_CR40","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1186\/s12913-021-06777-7","volume":"21","author":"S Garg","year":"2021","unstructured":"Garg S, Tripathi N, Ranjan A, Bebarta KK (2021) Comparing the average cost of outpatient care of public and for-profit private providers in India. BMC Health Serv Res 21(1):838","journal-title":"BMC Health Serv Res"},{"issue":"9767","key":"7328_CR41","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S0140-6736(10)61960-5","volume":"377","author":"KS Reddy","year":"2011","unstructured":"Reddy KS, Patel V, Jha P, Paul VK, Kumar AKS, Dandona L (2011) Towards achievement of universal health care in India by 2020: a call to action. Lancet Lond Engl 377(9767):760","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"7328_CR42","doi-asserted-by":"publisher","first-page":"e30362","DOI":"10.1371\/journal.pone.0030362","volume":"7","author":"S Prinja","year":"2012","unstructured":"Prinja S, Bahuguna P, Pinto AD, Sharma A, Bharaj G, Kumar V et al (2012) The cost of universal health care in India: a model based estimate. PLoS ONE 7(1):e30362","journal-title":"PLoS ONE"},{"issue":"2","key":"7328_CR43","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/hec.4730030206","volume":"3","author":"A Briggs","year":"1994","unstructured":"Briggs A, Sculpher M, Buxton M (1994) Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 3(2):95\u2013104","journal-title":"Health Econ"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-024-07328-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-024-07328-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-024-07328-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T09:57:02Z","timestamp":1739440622000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-024-07328-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["7328"],"URL":"https:\/\/doi.org\/10.1007\/s00198-024-07328-6","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,27]]},"assertion":[{"value":"18 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}